United States · Bill · S
S. 3105 (115th)
Pharmaceutical Origin Transparency Act of 2018
Introduced
21 June 2018
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
—
Subjects
Discovery layer
Source updated
11 August 2025
Summary
Pharmaceutical Origin Transparency Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act to require a drug manufacturer to publish information about each country in which its drugs are manufactured. (A drug is manufactured in a country if the active pharmaceutical ingredient is manufactured in such country.)
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 21 June 2018
Introduced in Senate (PDF)
Introduced in Senate · EN · 21 June 2018
Introduced in Senate
summary · EN · 21 June 2018
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/senate-bill/3105
- Open data entity: https://api.congress.gov/v3/bill/115/s/3105